Metropolis Healthcare vs Peers
- Market cap
- ₹11,299 crore
- P/E
- 56.0
- P/B
- 7.47
- ROE
- 13.4%
- Dividend yield
- 1.20%
Metropolis Healthcare ranks 3rd by market capitalisation among 8 Healthcare Service Provider companies tracked by ATS. Its largest peers are Dr. Lal Path Labs, Vijaya Diagnostic Centre and Thyrocare Technologies. Its P/E of 56.0 compares with a peer median of 46.6.
Metropolis Healthcare vs Healthcare Service Provider peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 1,950.50 | -0.70% | 32,569 | 60.1 | 12.99 | 21.6% | +12.5% |
| Vijaya Diagnostic Centre | 1,475.00 | +0.57% | 15,177 | 81.0 | 15.86 | 19.7% | +12.5% |
| Metropolis Healthcare | 545.00 | -1.38% | 11,299 | 56.0 | 7.47 | 13.4% | +22.0% |
| Thyrocare Technologies | 516.55 | -2.50% | 8,222 | 46.6 | 14.04 | 28.8% | +12.5% |
| Nephrocare Health Services | 643.15 | +1.36% | 6,453 | 75.8 | 5.78 | 9.0% | +12.5% |
| 3B Blackbio Dx | 1,640.70 | +4.16% | 1,408 | 25.4 | 4.34 | 20.2% | +12.5% |
| Health X Platform | 284.15 | -0.28% | 904 | 22.5 | 1.41 | 0.2% | +12.5% |
| Gaudium IVF and Women Health | 107.50 | -1.63% | 782 | 33.7 | 3.20 | 16.4% | +12.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 7 October 2026. How this data is compiled.
Metropolis Healthcare peer comparison — frequently asked questions
Who are Metropolis Healthcare's competitors?
Metropolis Healthcare's listed peers in Healthcare Service Provider include Dr. Lal Path Labs, Vijaya Diagnostic Centre, Thyrocare Technologies, Nephrocare Health Services, 3B Blackbio Dx and Health X Platform, ranked here by market capitalisation.
How does Metropolis Healthcare's P/E compare with its peers?
Metropolis Healthcare trades at a P/E of 56.0, against a median of 46.6 across the 7 Healthcare Service Provider peers shown.
Which is the largest company among Metropolis Healthcare's peers?
By market capitalisation, the largest company in the group is Dr. Lal Path Labs at ₹32,569 crore, against ₹11,299 crore for Metropolis Healthcare.
Same Data For Peers
Trade Metropolis Healthcare With ATS
Track METROPOLIS live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.